Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29466164 | 1.00 | L3MBTL1 (0.55) | L3MBTL1ALDH1A1CHRM2NPSR1NPC1 | |
| Ammonia Solution, Strong SCHEMBL3313079 | 0.98 | L3MBTL1 (0.54) | L3MBTL1ALDH1A1CHRM2NPSR1NPC1 | |
| SCHEMBL29860055 | 0.91 | L3MBTL1 (0.62) | L3MBTL1ALDH1A1CHRM2SMN1; SMN2MEN1 | |
| SCHEMBL3314110 | 0.91 | L3MBTL1 (0.62) | L3MBTL1ALDH1A1CHRM2SMN1; SMN2MEN1 | |
| SCHEMBL12963429 | 0.86 | RAB9A (0.57) | L3MBTL1ALDH1A1CHRM2NPSR1NPC1 | |
| SCHEMBL2947235 | 0.85 | ALDH1A1 (0.63) | L3MBTL1ALDH1A1CHRM2SMN1; SMN2MEN1 | |
| SCHEMBL2854302 | 0.85 | CYP1A2 (0.56) | L3MBTL1ALDH1A1CHRM2NPSR1ALOX15 | |
| SCHEMBL29438821 | 0.83 | CHRM2 (0.70) | L3MBTL1ALDH1A1CHRM2SMN1; SMN2MEN1 | |
| SCHEMBL230222 | 0.83 | CHRM2 (0.70) | L3MBTL1ALDH1A1CHRM2SMN1; SMN2MEN1 | |
| SCHEMBL3906840 | 0.83 | ALDH1A1 (0.55) | L3MBTL1ALDH1A1CHRM2SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113512039-B | Cu detection based on complexation+Fluorescent probe and application thereof | 广东石油化工学院 | 2022-03-29 | — | — | CN | claimed |
| CN-113512039-A | Cu detection based on complexation+Fluorescent probe and application thereof | 广东石油化工学院 | 2021-10-19 | — | — | CN | claimed |
| US-20250136594-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2025-05-01 | — | — | US | disclosed |
| EP-4469438-A1 | COMPOUNDS AND METHODS OF USE | Tango Therapeutics, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| WO-2023146987-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146987-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| CN-113512039-B | Cu detection based on complexation+Fluorescent probe and application thereof | 广东石油化工学院 | 2022-03-29 | — | — | CN | disclosed |
| CN-113512039-A | Cu detection based on complexation+Fluorescent probe and application thereof | 广东石油化工学院 | 2021-10-19 | — | — | CN | disclosed |
| WO-2004069823-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE, INC. (CA) | 2004-08-19 | — | — | WO | disclosed |
| WO-2003024448-A2 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE, INC. (CA) | 2003-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250136594-A1 | COMPOUNDS AND METHODS OF USE | CNKSR1, UGT1A1, REV1 | L3MBTL1 4699/4885ALDH1A1 29/4885CHRM2 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.